Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2024-12-13 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
第二届监事会第十七次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Shenzhen Huitai Medical Devices Co., Ltd. It details the approval of various proposals related to the use and management of raised funds, investment adjustments, related party transactions, and share repurchase plans. The document includes voting results and references to more detailed announcements published separately on the Shanghai Stock Exchange website. The document length is 3085 characters, which is relatively short and primarily serves as a formal announcement of meeting resolutions rather than a full report or detailed financial disclosure. It does not contain financial statements or detailed financial analysis but rather summarizes supervisory board decisions and approvals. Therefore, it fits best into the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2024-12-13 Chinese
关于变更注册资本暨修订《公司章程》的公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement from Shenzhen Huitai Medical Equipment Co., Ltd. regarding changes in registered capital and amendments to the company's articles of association. It details the increase and decrease in shares due to stock incentive plans and share cancellations, and the corresponding changes in registered capital. It also mentions the proposed amendments to the company's articles of association and that these changes will be submitted to the shareholders' meeting for approval. The document is a formal announcement of corporate governance and capital structure changes, not a full report or financial statement. It is not a full Annual Report, Interim Report, or any detailed financial report. It is also not a simple notice of dividend, nor a voting result declaration. The content fits best with announcements about capital changes and related corporate governance updates. Therefore, the most appropriate classification is Share Issue/Capital Change (SHA). The document length is short (1580 characters), and it contains substantive information about capital changes, not just a report publication announcement or regulatory filing. Confidence is high due to clear content and context.
2024-12-13 Chinese
2024年第四次独立董事专门会议决议
Board/Management Information Classification · 95% confidence The document is titled as a resolution from the company's independent directors meeting, specifically the 2024 fourth independent directors special meeting. It discusses approval of proposals related to anticipated related party transactions for 2025 and waiving preemptive rights, with voting results included. The content focuses on governance and internal board decisions rather than financial results or regulatory filings. The document length is short (1007 characters) and it is a formal meeting resolution by independent directors, which fits best under Board/Management Information (MANG) as it relates to board-level decisions and approvals. There is no indication of financial statements, audit reports, or regulatory announcements. Therefore, the classification is MANG with high confidence.
2024-12-13 Chinese
关于调整公司回购股份用途并注销暨减少注册资本的公告
Transaction in Own Shares Classification · 95% confidence The document is an official announcement from Shenzhen Huitai Medical Device Co., Ltd. regarding the adjustment of the purpose of the company's share repurchase and the cancellation and reduction of registered capital. It details the board and supervisory committee meetings approving the change, the number of shares to be cancelled, the impact on share capital, and the legal and procedural compliance. The document is a formal announcement about a change in the use of repurchased shares and the related capital reduction, not a financial report or earnings release. It fits the description of a Transaction in Own Shares (POS) filing, which covers company buybacks and share cancellations. The document length is 2561 characters, which is consistent with an announcement rather than a full report. Therefore, the correct classification is POS with high confidence.
2024-12-13 Chinese
中信证券股份有限公司关于深圳惠泰医疗器械股份有限公司使用募集资金及自有资金向全资子公司增资的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from CITIC Securities regarding Shenzhen Huitai Medical Device Co., Ltd.'s use of raised funds and own funds to increase capital in its wholly-owned subsidiary. It references regulatory approvals, fundraising details, investment projects, board and supervisory approvals, and compliance with relevant laws and regulations. The document is a formal verification or audit opinion related to the use of funds and capital increase, not a full annual or interim report, nor a simple announcement. It contains substantive financial data and detailed analysis of the capital use and compliance, fitting the definition of an Audit Report / Information (AR). The document length is 4317 characters, which is sufficient for a detailed audit opinion rather than a brief announcement. Therefore, the classification is AR with high confidence. H1 2024
2024-12-13 Chinese
关于部分募投项目延期及调整投资金额的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Shenzhen Huitai Medical Devices Co., Ltd. regarding the delay and adjustment of investment amounts in certain fundraising projects. It details changes in the investment schedule and amounts for specific projects funded by proceeds from the company's initial public offering (IPO). The document includes references to regulatory approvals, fundraising amounts, project progress, and board and supervisory committee approvals. It is a formal disclosure about changes to the use of raised capital, including the need for shareholder approval. The content focuses on capital raising and investment project updates rather than financial results, management changes, or legal proceedings. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is sufficient and contains substantive details about capital use adjustments, not just a brief announcement or a report publication notice.
2024-12-13 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.